Agrawal Sahil, Gupta Saloni, Gupta Noopur, Vanathi Murugesan, Tandon Radhika
Senior Research Officer, Dr R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Faculty (Ophthalmology), Northern Railway Central Hospital, New Delhi, India.
Med J Armed Forces India. 2024 Sep-Oct;80(5):522-527. doi: 10.1016/j.mjafi.2022.06.014. Epub 2022 Aug 16.
To determine the efficacy of sodium chloride (NaCl) 5% drops in comparison to 6% ointment and study tear Osmolarity as an objective measure correlating with clinical findings in the treatment of corneal edema.
This is a prospective, randomized, interventional, open-label, crossover study of 40 eyes of 40 patients with corneal edema due to Bullous keratopathy and Fuchs endothelial dystrophy. Subjects were divided into 2 groups by simple randomization: group A received NaCl 5% drops and group B received NaCl 6% ointment. Both treatments were administered four times daily for seven days. Subsequently, after a 1-week wash-out period, switch over of treatment was done. Central corneal thickness (CCT) and tear osmolarity were primarily efficacy variables.
Baseline parameters were comparable. The median reduction in CCT from baseline (706.7 ± 58.41 μm), at 6 hours with NaCl 5% drops was 23 μm (-27, 74) and that with NaCl6% ointment was 37.5 μm (-7, 85). The reduction in CCT was more with 6% ointment (p = 0.013). The difference in reduction in CCT between two treatments at one week was not statistically significant, although there was a substantial reduction in thickness with each treatment individually. The change in tear osmolarity from the baseline at 2 Hours with both NaCl5% drops and 6% ointment was significant, and it remained so till 6 h. Side-effects such as stickiness, stinginess, blurring, and foreign body sensation were more with 6% eye ointment.
Topical NaCl 6% eye ointment in QID dosage is more effective than NaCl 5% drops in the medical management of corneal edema. In patients symptomatically intolerant to ointment, NaCl 5% eye drops may be prescribed as an effective option.
为了确定5%氯化钠(NaCl)滴眼液相对于6%眼膏的疗效,并研究泪液渗透压作为与角膜水肿治疗中临床发现相关的客观指标。
这是一项前瞻性、随机、干预性、开放标签、交叉研究,纳入了40例因大疱性角膜病变和Fuchs内皮营养不良导致角膜水肿的患者的40只眼睛。通过简单随机化将受试者分为2组:A组接受5% NaCl滴眼液,B组接受6% NaCl眼膏。两种治疗均每日给药4次,持续7天。随后,在1周的洗脱期后,进行治疗切换。中央角膜厚度(CCT)和泪液渗透压是主要的疗效变量。
基线参数具有可比性。使用5% NaCl滴眼液在6小时时,CCT从基线(706.7 ± 58.41μm)的中位降低值为23μm(-27,74),使用6% NaCl眼膏的降低值为37.5μm(-7,85)。6%眼膏使CCT降低得更多(p = 0.013)。尽管每种治疗单独使用时厚度都有显著降低,但两种治疗在1周时CCT降低的差异无统计学意义。使用5% NaCl滴眼液和6%眼膏在2小时时泪液渗透压相对于基线的变化均显著,并且直到6小时都保持显著。6%眼膏的副作用如粘性、刺痛感、视物模糊和异物感更多。
每日4次给药的局部用6% NaCl眼膏在角膜水肿的药物治疗中比5% NaCl滴眼液更有效。对于有症状地不耐受眼膏的患者,可开具5% NaCl滴眼液作为一种有效的选择。